Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT
Abstract Candidates for prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) of metastatic castration-resistant prostate cancer (mCRPC) frequently have “mismatch” lesions with pronounced 18-fluorodeoxyglucose ([18F]FDG) but attenuated PSMA ligand uptake on positron emission t...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Portfolio
2024-05-01
|
| Sarja: | Scientific Reports |
| Aiheet: | |
| Linkit: | https://doi.org/10.1038/s41598-024-61961-z |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|